
|Podcasts|October 18, 2021
ROP: Treating and preventing blindness in preterm babies
Author(s)Alex Delaney-Gesing
Retinopathy of prematurity expert C. Armitage Harper, III, MD, of the Austin Retina Associates in Austin, Texas, discusses his experience in treating ROP cases across the globe, and his mission to prevent pre-term blindness in infants.
Advertisement
Retinopathy of prematurity (ROP) expert C. Armitage Harper, III, MD, of the Austin Retina Associates in Austin, Texas, discusses his focus on treating ROP in infants across the globe, the gross inequity in ROP diagnosis and treatment between western countries and the rest of the world, as well efforts being made — and should be made — to prevent blindness in pre-term babies.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
2
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
3
NCX 470 gains positive regulatory feedback in China ahead of US NDA submission
4
Label Updates and Dosing Flexibility in Retinal Vascular Diseases
5























